This groundbreaking research, spearheaded by Joy et al., delves into the qualitative experiences of participants engaging in qigong as a means to manage their residual COVID-19 symptoms. The study aims to shine a light on the deeply personal and subjective journeys of individuals coping with the multifaceted challenges posed by PASC. Gathering such qualitative data provides valuable insights that are often overlooked in quantitative studies, where numbers and statistics reign supreme. By focusing on the lived experiences of these individuals, the researchers hope to uncover the nuanced ways in which qigong may facilitate recovery and improve overall well-being.

The practice of qigong dates back thousands of years and is rooted in traditional Chinese medicine. Encompassing various techniques, including gentle exercise, breath regulation, and meditation, qigong is more than just a physical activity; it represents a holistic approach to health that seeks to harmonize the body, mind, and spirit. As Western medicine continues to explore complementary and alternative therapies in the context of chronic illnesses, qigong has come into the spotlight as a potential supportive intervention for individuals suffering from PASC.

Participants in the study reported a diverse array of PASC symptoms, which ranged from fatigue and brain fog to anxiety and depression. Many individuals expressed frustration and helplessness as they navigated these lingering effects, often feeling as though they had been abandoned by the conventional healthcare system after the acute phase of their illness had resolved. In response to this unmet need, the introduction of qigong offered not only a potential therapeutic avenue but also a sense of community and support among participants who shared similar experiences.

Throughout the trial, participants were encouraged to engage with qigong practices regularly, and their experiences were documented through interviews, journals, and feedback sessions. This qualitative approach allowed the researchers to capture the rich, emotional experiences of individuals, offering a deeper understanding of how qigong might impact various aspects of life for those affected by PASC. Participants described feelings of increased energy, improved sleep quality, and enhanced mental clarity, all of which contributed to a sense of empowerment in their healing journeys.

Moreover, many participants emphasized the importance of the meditative aspects of qigong, reporting that the practice helped them cultivate mindfulness and presence amidst the chaos of their symptoms. This aspect of qigong may play a crucial role in mitigating anxiety and depression, common emotional responses to the uncertainty and struggles associated with PASC. By fostering a mind-body connection, qigong may provide individuals with the tools necessary to cope more effectively with their symptoms and reclaim a sense of agency over their health.

As the data collected from this pilot study continues to be analyzed, the researchers are excited about the potential for more substantial clinical trials that could further solidify the role of qigong in managing PASC. Such studies could pave the way for integrating complementary therapies like qigong into conventional treatment protocols, thereby offering a more holistic approach to recovery for individuals experiencing long-term effects from COVID-19.

Furthermore, the growing body of evidence supporting the positive outcomes of mind-body practices in the context of chronic illnesses highlights the importance of expanding research in this area. While traditional medical interventions play a critical role in treating the acute phase of COVID-19, understanding and addressing the psychosocial dimensions of recovery is equally vital. The experiences of individuals engaging in qigong provide a valuable foundation for this dialogue, demonstrating the need for a multifaceted approach to health that encompasses both physical and emotional well-being.

The insights gleaned from Joy et al.’s research have the potential to resonate far beyond the realm of PASC. In a world increasingly afflicted by chronic stress, anxiety, and emotional upheaval, practices like qigong may offer a beacon of hope. As individuals seek ways to navigate their health challenges and promote resilience in the face of adversity, the healing power of mindfulness and physical movement cannot be underestimated. The collective experiences shared by participants in this pilot study serve as a reminder of the strength inherent in community, connection, and our innate ability to heal.

Looking to the future, the continued exploration of qigong and other complementary therapies in the context of various health conditions can inform a more integrated approach to healthcare. As society moves forward from the pandemic, the lessons learned from this research will be instrumental in shaping the dialogue surrounding chronic illness and recovery. By fostering an environment that values both traditional and alternative healing modalities, healthcare providers can better support individuals as they navigate their health journeys.

In conclusion, Joy et al.’s qualitative analysis provides a poignant glimpse into the experiences of individuals grappling with PASC. The findings underscore the need for innovative approaches to treatment that honor the complexities of human health and experience. Qigong may represent one of many pathways toward healing, offering not just physical relief but also a sense of hope and belonging to those affected by the lingering impacts of COVID-19. As the world continues to grapple with the ramifications of the pandemic, the potential of practices like qigong to facilitate recovery and promote resilience cannot be overlooked.

By bringing awareness to the lived experiences of individuals pursuing healing through qigong, this research illuminates a vital aspect of recovery—one that highlights the intrinsic connection between mind, body, and community. As we look toward the future, the need for continued exploration in this domain will undoubtedly shape the landscape of healthcare and healing for years to come.

Subject of Research: The effects of qigong on post-acute sequelae of COVID-19 (PASC) symptoms.

Article Title: Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants’ experiences in a pilot clinical trial.

Article References:

Joy, M., Adams, N., Yanuck, M. et al. Experiences with Qi and changes in post-acute sequelae of COVID-19 (PASC) symptoms with qigong: a qualitative analysis of participants’ experiences in a pilot clinical trial.
BMC Complement Med Ther 25, 434 (2025). https://doi.org/10.1186/s12906-025-05161-w

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12906-025-05161-w

Keywords: COVID-19, PASC, qigong, qualitative research, holistic health, mind-body connection, chronic illness, mental health.

The PASC score was developed to provide a standardized tool for clinicians to evaluate and efficiently diagnose symptoms of long COVID. It takes into account a variety of factors, including neurological, respiratory, and cardiovascular symptoms. Patients have reported a myriad of post-viral symptoms ranging from fatigue and depression to chest pain and shortness of breath. Given the diverse array of symptoms, establishing an accurate diagnostic criterion is essential not just for clinical practice but also for research aimed at understanding long COVID’s pathophysiology and potential treatment options.

In their groundbreaking article, Azola and colleagues explore how precisely the PASC score correlates with clinical evaluations, aiming to determine whether the score can serve as a standalone diagnostic tool. The researchers executed a comparative study that involved patient assessments and extensive statistical analyses. Their findings are particularly poignant, given that many clinicians are still struggling with how best to identify and treat long COVID, a condition that defies conventional diagnostic methods.

The study involved a broad spectrum of participants, capturing a diversity of experiences with long COVID. Researchers meticulously collected data through questionnaires that assessed a variety of symptoms and their severity. This comprehensive approach would allow the authors to draw meaningful conclusions about the PASC score’s performance. By juxtaposing clinical evaluations against the PASC score, they could discern the areas where the score excels and where it might fall short.

One of the key revelations from the study was the score’s unexpected variability in accuracy among different demographics. While the PASC score may have been initially assessed as an effective diagnostic tool, the team’s findings raised questions about its universal applicability across diverse populations. Some patient cohorts displayed a significant discrepancy between their clinical symptoms and their corresponding PASC scores, thus highlighting a need for more adaptable diagnostic criteria that encompass the various manifestations of long COVID.

The implications of this research extend beyond diagnostic criteria; they touch directly on the potential for improved treatment strategies and healthcare support for those afflicted with long COVID. Accurate diagnosis is often the precursor to effective treatment. If clinicians cannot reliably identify an underlying condition, the result may be inadequate care or, worse, misdiagnosis. The risk of medical gaslighting could result in patients feeling isolated and misunderstood as they navigate their long-term recovery journeys.

Statistical accuracy is another cornerstone of this study. By engaging in rigorous analyses of the relationship between the PASC score and clinical findings, the researchers positioned their inquiry within a framework of empirical evidence. This commitment to statistic validity enhances the credibility of their conclusions, as it underscores the importance of data-driven decision-making in clinical settings. The team employs advanced statistical methodologies to scrutinize the results, accounting for variables that could influence outcomes.

One interesting finding from their analysis was the importance of patient-reported outcomes in bolstering the predictive power of the PASC score. When patients self-reported their symptoms, combined with clinical evaluations, researchers noted enhanced diagnostic accuracy. This intersection of subjective experience and objective measurement is vital; it indicates that medical professionals might achieve more precision by integrating patient narratives into their assessments.

Moreover, the study emphasizes the urgent need for further research into the underlying mechanisms of long COVID. Identifying a robust diagnostic tool, while essential, remains one part of a larger puzzle. Understanding the biological pathways that contribute to long COVID will allow researchers and clinicians to better classify syndromes and tailor treatments that address not only symptoms but also the root causes of prolonged illness.

Equally significant are the social and economic factors associated with long COVID, which the article subtly alludes to. A widespread and effective diagnostic criteria could facilitate access to necessary healthcare services, disability benefits, and social systems designed to support those unable to return to their pre-COVID lives. Thus, the importance of accurate diagnosis transcends the individual, impacting public health systems on a larger scale.

As the research community continues to grapple with the repercussions of the COVID-19 pandemic, the validation or invalidation of tools like the PASC score will significantly impact future public health strategies. Policymakers, healthcare providers, and researchers must remain vigilant in their efforts to adapt evidence-based strategies in response to evolving data and patient needs.

Ultimately, as Azola, Dastgheyb, and Easter’s study illustrates, the quest to ascertain the true efficacy of the PASC score in long COVID diagnosis embodies a larger narrative about our collective struggle against lingering COVID effects. It exemplifies the critical need for a flexible, evidence-based approach to diagnosing complex conditions to ensure that all patients receive the care and understanding they rightfully deserve.

In conclusion, the exploration of the PASC score’s clinical versus statistical accuracy provides critical insights into the evolving landscape of long COVID diagnosis. As this field progresses, the study underscores the responsibility of the medical community to prioritize accuracy, patient engagement, and ongoing research into long COVID’s etiology. This commitment will facilitate the development of effective diagnostic tools and treatments, ultimately improving the lives of countless individuals worldwide.

Subject of Research: The clinical versus statistical accuracy of the PASC score in diagnosing long COVID.

Article Title: Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis.

Article References:

Azola, A., Dastgheyb, R.M., Easter, R. et al. Putting the PASC Score to the Test: Clinical vs. Statistical Accuracy in Long COVID Diagnosis.
J GEN INTERN MED (2025). https://doi.org/10.1007/s11606-025-10042-6

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11606-025-10042-6

Keywords: Long COVID, PASC score, clinical diagnostic accuracy, statistical validity, public health.

Long COVID, medically referred to as post COVID-19 condition, is characterized by neurological, respiratory, and gastrointestinal symptoms persisting or arising more than three months after the initial SARS-CoV-2 infection. Epidemiological data have consistently demonstrated that women are approximately three times more likely than men to develop long COVID, but until now, the biological mechanisms underpinning this disparity remained elusive. The research, led by immunology expert Professor Shokrollah Elahi at the University of Alberta’s Mike Petryk School of Dentistry, employed extensive immunological, hormonal, and transcriptomic profiling on individuals afflicted by long COVID one year post-infection.

The investigative team conducted a comprehensive observational study involving 78 long COVID patients alongside 62 control individuals who recovered fully without chronic symptoms following SARS-CoV-2 infection. Utilizing cutting-edge techniques including immune cell phenotyping, biomarker assessment, and RNA sequencing, the researchers identified a distinctive immunological signature that varied drastically between female and male patients with long COVID. This signature implicates immune dysregulation and systemic inflammation pathways that are potentially sex-specific.

One of the most striking findings highlighted a phenomenon termed “gut leakiness” predominantly in female participants. Elevated plasma concentrations of intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), and soluble CD14 were observed, all biomarkers indicative of intestinal barrier dysfunction and gut inflammation. This gut permeability allows translocation of microbial products into the bloodstream, fostering a heightened systemic inflammatory state. The study theorizes that female patients may have a biological predisposition for increased vulnerability of intestinal integrity at the earliest phase of SARS-CoV-2 infection, contributing to their prolonged symptomatology.

Moreover, female participants exhibited signs of anemia, denoting impaired erythropoiesis. This was correlated with elevated circulating inflammatory cytokines, suggesting that persistent inflammation might interfere with red blood cell production mechanisms in women with long COVID. Contrastingly, anemia was not a hallmark feature among male patients, a separation that raises significant questions about sex-differentiated inflammatory responses and hematopoietic regulation in post-viral syndromes.

Crucially, the investigation also unraveled pervasive sex hormone imbalances among long COVID patients. The data revealed abnormally low testosterone levels in affected women and diminished estrogen concentrations in male subjects. Furthermore, cortisol levels, a stress hormone integral to modulating immune responses, were reduced in both sexes. Testosterone’s anti-inflammatory properties imply that its deficiency could exacerbate inflammatory cascades, thereby amplifying symptom severity specifically in female patients. Notably, women with diminished testosterone exhibited exacerbated cognitive dysfunction, depression, musculoskeletal pain, and profound fatigue, aligning with clinical features of ME/CFS.

This hormonal dysregulation could represent a key driver of long COVID pathology. Given that sex hormones modulate immune system activity, the altered hormonal milieu in patients might hinder resolution of the hyperinflammatory state triggered by the initial viral infection. This offers a compelling biological explanation for the gender disparity seen in long COVID outcomes, emphasizing the need to incorporate endocrine evaluations in clinical management protocols.

The study’s revelations resonate with existing literature on chronic fatigue syndrome, a disorder which similarly manifests sex-biased prevalence favoring women. While chronic inflammation is a shared characteristic, the distinct presence of anemia in female long COVID patients marks a divergence in pathophysiological patterns between these two clinical entities. Notably, the researchers’ findings are corroborated by a large-scale international investigation involving over 500 long COVID patients, which also identified anemia as a significant biological underpinning, thereby lending robust external validation to these discoveries.

Looking to the future, Professor Elahi and his collaborators aim to further validate their findings through experimental long COVID mouse models, which will enable controlled evaluation of potential therapeutic interventions. The investigative team is actively pursuing funding to initiate human clinical trials designed to test individualized treatment strategies tailored to patients’ unique biological profiles, potentially incorporating anemia correction, targeted anti-inflammatory agents, and hormonal modulation therapies.

The personalized medicine approach proposed by Elahi pioneers a paradigm shift in long COVID management, moving away from generalized therapies toward precision interventions. Such an approach could dramatically improve patient outcomes by addressing specific biological derangements identified through thorough profiling, which might otherwise perpetuate symptom chronicity and functional decline.

Finally, the research team intends to explore overlapping neurological sequelae observed in long COVID and other chronic viral infections such as HIV. Understanding shared and distinct molecular pathways across these conditions may pave the way for novel insights into neuroinflammation and post-viral syndromes, broadening therapeutic horizons.

This landmark study was supported by the Canadian Institutes of Health Research and the Li Ka Shing Institute of Virology, with significant contributions from a multidisciplinary group including immunologists, clinicians, and molecular biologists. The translational potential of these findings could mark a turning point in addressing one of the most challenging and widespread post-pandemic health crises affecting millions worldwide.

Subject of Research: People

Article Title: Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS

News Publication Date: 7-Nov-2025

Web References:

• Cell Reports Medicine Article
• Post COVID-19 condition Fact Sheet – WHO
• Statistics Canada on Long COVID
• Recent International Long COVID Study
• ME/CFS Information – CDC

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), remains one of the most perplexing and enduring challenges posed by the COVID-19 pandemic. Characterized by symptoms such as persistent fatigue, cognitive impairment often described as "brain fog," and other nebulous complaints, long COVID can debilitate individuals weeks or even months after the acute viral episode has resolved. Despite considerable scientific effort, the pathophysiological mechanisms underlying this heterogeneous syndrome remain elusive, complicating efforts to develop targeted treatments.

The study focused specifically on children and adolescents, an age group that has received comparatively less attention in the discourse surrounding long COVID and vaccination benefits. This decision is pivotal because immune responses and the clinical progression of COVID-19 can differ substantially between younger populations and adults, potentially influencing the incidence and severity of long-term sequelae. Utilizing de-identified electronic health records from nearly 400,000 minors across the United States, the research team analyzed data spanning the dominant COVID variant waves of 2021 and 2022, namely Delta and Omicron.

Participants were stratified into three cohorts for precise comparative analysis: 112,590 adolescents aged 12 to 20 during the Delta-dominant period (July to November 2021), 188,894 children aged 5 to 11, and 84,735 adolescents during the Omicron wave (January to November 2022). The team employed sophisticated statistical methodologies, including mediation analysis, to disentangle the dual protective effects of vaccination — prevention of infection and mitigation of long COVID risk post-infection.

During the Delta surge, the vaccine exhibited an impressive 95 percent effectiveness in reducing the risk of long COVID among adolescents. This figure was derived from incidence rates of 0.11 cases per 10,000 person-weeks in vaccinated individuals versus 3.54 in unvaccinated peers, indicating a striking 32-fold difference. The Omicron wave showed a somewhat reduced yet still substantial protective effect, with vaccine effectiveness estimated at 60 percent for younger children and 75 percent for adolescents in preventing long COVID.

Crucially, the mediation analysis performed by the researchers revealed that once an infection occurs, vaccinated and unvaccinated children and adolescents exhibit comparable probabilities of developing long COVID. This finding suggests that the vaccine’s primary role in reducing long COVID risk operates by significantly lowering the likelihood of initial infection. In other words, vaccination indirectly prevents long COVID by functionally acting as a barrier to viral acquisition at the outset.

The implications of these results are profound for public health policies targeting pediatric populations. As vaccination campaigns progress, emphasizing their role in infection prevention could enhance public compliance and retention, particularly amid ongoing concerns about vaccine safety and efficacy. The research underscores the vital importance of maintaining high immunization coverage in youth to mitigate not only acute COVID-19 outcomes but also the longer-term burden of PASC.

Furthermore, these findings contribute to the growing body of evidence that questions some earlier assumptions about vaccination’s potential to attenuate post-infection syndromes directly. While vaccines undoubtedly prime the immune system to combat SARS-CoV-2 more effectively, their influence on the immunopathological processes driving long COVID once infection occurs may be limited in children and adolescents.

The study is part of the NIH-sponsored RECOVER initiative, which aggregates extensive electronic health record datasets from health systems nationwide to advance understanding of long COVID. By leveraging real-world data, this research provides robust evidence that complements controlled clinical trials, offering nuanced insights into vaccine impact across diverse populations and viral variants.

Co-authors Yong Chen, PhD, and Jeffrey Morris, PhD, leaders in biostatistics at Penn Medicine, highlight that prior studies often did not fully account for the confounding effect of infection risk reduction when comparing vaccinated and unvaccinated groups. This oversight may have contributed to the inconsistent findings reported in earlier literature regarding vaccine protection against long COVID.

As the COVID-19 pandemic evolves, particularly with the emergence of novel variants and the prospect of repeated exposures, this study emphasizes that vaccination remains the front-line defense in preventing both acute and chronic sequelae among the younger demographic. The protective effect against long COVID is intrinsically linked to preventing the virus from establishing infection, reinforcing vaccination as a critical preventative strategy.

In conclusion, vaccination in children and adolescents acts predominantly by blocking SARS-CoV-2 infection, thereby indirectly reducing long COVID incidence. While the vaccine does not appear to confer additional protective benefits once infection occurs, its role in curbing initial viral exposure holds immense significance in controlling the long-term public health impact of COVID-19. This research highlights the necessity of ongoing vaccination efforts and may inform future recommendations for pediatric immunization schedules and public health messaging.

Subject of Research: People

Article Title: Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents

Web References:
DOI: 10.1016/j.eclinm.2024.102962

Keywords:
Long Covid, COVID 19 vaccines, Adolescents, Research on children, Statistical analysis, Disease prevention, Children, SARS CoV 2, Disease control

The term "post-COVID-19 syndrome" encompasses a range of health issues that manifest after the acute phase of SARS-CoV-2 infections. While the public discourse frequently revolves around the immediate aftermath of COVID-19, the long-term effects — often referred to as long COVID — are less understood, leading to widespread concern among medical professionals and the general populace alike. The research involved a meticulous examination of 982 individuals aged between 18 and 65 years who had been previously diagnosed with PCS and contrasted them against 576 control subjects without the syndrome.

Participants in the study underwent comprehensive assessments at several university health centers located in southwestern Germany. These evaluations included a spectrum of tests to assess cognitive function, cardiopulmonary exercise capacity, and detailed laboratory analysis. Such a thorough approach is unprecedented in PCS research and underscores the need for robust clinical methodologies to understand the condition.

Among the various clusters of symptoms identified, fatigue and exhaustion emerged as prominent indicators, affecting nearly 68% of those surveyed. Furthermore, neurocognitive disruptions were common, illustrating how COVID-19 does not solely impact the respiratory system but also has deep neurological implications. Alongside these symptoms, many participants also reported experiences of chest discomfort, breathlessness, and psychological challenges, including anxiety and sleep disturbances.

An especially striking finding from the study is the prevalence of exercise intolerance coupled with post-exertional malaise. This debilitating symptom was reported in more than a third of subjects with PCS, revealing how the condition can drastically impair everyday functioning. It is worth noting that individuals with lower educational attainment, obesity, or a more severe initial illness were more susceptible to prolonged symptoms, indicating that socioeconomic factors may play a critical role in the development of PCS.

In examining objective health metrics, researchers discovered that those with persistent PCS exhibited notable deficits in measures such as handgrip strength, maximal oxygen consumption, and ventilatory efficiency. These findings further emphasize the physiological repercussions of the syndrome. Cognitive assessments revealed that patients suffering from persistent PCS, particularly those with post-exertional malaise, scored considerably lower than their control counterparts in tests meant to evaluate memory, attention, and processing speed. However, the researchers acknowledged a significant gap in the available data, particularly the absence of cognitive function assessments conducted prior to the acute COVID-19 illness.

The implications of these findings are profound, calling into question standard clinical practices surrounding the management of PCS. The researchers advocate for incorporating cognitive and exercise testing into routine evaluations for individuals suspected of having the syndrome. Such a paradigm shift could enhance monitoring and tailored interventions, ultimately improving outcomes for a growing cohort of patients grappling with the enduring aftermath of COVID-19.

Moreover, the authors stress the pressing need for observational studies with more extended follow-ups. Evaluating the myriad of factors that contribute to recovery or non-recovery from PCS will provide critical insights and assist in devising effective treatment strategies. It is evident that the complexities of long COVID extend beyond what can be captured in laboratory markers; the interplay of mental and physical health factors presents unique challenges for healthcare practitioners.

These findings signal a call to action within both public health and clinical settings. As the world continues to grapple with the ramifications of the COVID-19 pandemic, understanding the long-term impacts on survivors will be essential in shaping effective response strategies. Furthermore, community and global healthcare systems must prioritize research efforts aimed at elucidating the specific mechanisms underpinning PCS to tailor interventions accordingly.

Acknowledging the multifaceted nature of PCS is imperative. Future research must delve deeper into the pathophysiological mechanisms contributing to the syndrome’s persistence, offering vital clues to capable therapeutic modalities. By understanding the specific symptoms and their interrelations, healthcare professionals can better equip themselves to address the complexities of this condition and empower those affected with knowledge, support, and resources.

In conclusion, the landscape of post-COVID-19 syndrome is one marked by uncertainty yet filled with urgency. As researchers work tirelessly to uncover new understandings of the syndrome, it is clear that immediate and long-term support for individuals affected by PCS must remain a priority. The findings from the recent study catalyze a broader conversation about ongoing health challenges and the necessity of robust interdisciplinary approaches to address the legacy of COVID-19.

Subject of Research: People
Article Title: Persistent Symptoms and Clinical Findings in Adults with Post-Acute Sequelae of COVID-19/Post-COVID-19 Syndrome in the Second Year After Acute Infection
News Publication Date: January 23, 2025
Web References: PLOS Medicine
References: Kern, W., Nieters, A., Göpel, S., Merle, U., Steinacker, J. M., et al. (2025). Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study. PLoS Med 22(1): e1004511.
Image Credits: PIRO4D, Pixabay (CC0)

Keywords: Post-COVID-19 syndrome, long COVID, persistent symptoms, cognitive impairments, exercise intolerance, health study, Freiburg University, PLOS Medicine.